Surgical robotics specialist Medrobotics Corp. has closed on a $20 million preferred stock financing. Proceeds will be used to fund the Raynham, Mass.-based company’s expansion into new surgical applications, such as single-port general and gynecological surgeries, and to develop its next generation Flex Robotic System with more fully robotic instrument options. The company has FDA clearance and CE mark for the device.